Published in Nat Rev Neurol on December 29, 2015
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses (2016) 0.81
Role of Envelopment in the HEV Life Cycle. Viruses (2016) 0.78
Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses (2016) 0.76
Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France. J Virus Erad (2016) 0.75
Markers for Ongoing or Previous Hepatitis E Virus Infection Are as Common in Wild Ungulates as in Humans in Sweden. Viruses (2016) 0.75
Hepatitis E Virus Infection and Cirrhosis of the Liver. Gastroenterol Hepatol (N Y) (2016) 0.75
Hepatitis E Pathogenesis. Viruses (2016) 0.75
Molecular Biology and Infection of Hepatitis E Virus. Front Microbiol (2016) 0.75
Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient. J Neurovirol (2017) 0.75
Prevalence and Molecular Characterization of the Hepatitis E Virus in Retail Pork Products Marketed in Canada. Food Environ Virol (2017) 0.75
HIV positive patient with GBS-like syndrome. JMM Case Rep (2017) 0.75
Guillain-Barré syndrome. Lancet (2005) 8.73
Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med (2008) 6.60
Hepatitis E. Lancet (2012) 4.43
Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis (2008) 3.70
HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol (2000) 3.66
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology (1998) 3.13
Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med (2009) 2.93
Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis (2011) 2.75
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet (2014) 2.72
A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol (2010) 2.54
The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain (2005) 2.51
The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology (2012) 2.31
Hepatitis E virus infection. Clin Microbiol Rev (2014) 2.21
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis (2005) 2.18
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther (2014) 2.11
Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol (2008) 2.06
Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang (2012) 2.03
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology (2011) 2.01
Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis (2009) 1.99
Hepatitis E. N Engl J Med (2012) 1.99
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain (2013) 1.93
Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol (2004) 1.85
Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis (2010) 1.75
Hepatitis E virus and neurologic disorders. Emerg Infect Dis (2011) 1.70
Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol (2005) 1.62
Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol (2004) 1.58
HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis (2014) 1.54
Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill (2013) 1.51
Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré Study Group. Neurology (1996) 1.45
Guillain-Barré syndrome and encephalitis/encephalopathy of a rare case of Northern China acute severe hepatitis E infection. Neurol Sci (2014) 1.43
Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol (2011) 1.42
Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol (2012) 1.39
Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin Infect Dis (2002) 1.37
An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion (2013) 1.36
Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology (2014) 1.33
Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med (2008) 1.32
Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol (2009) 1.29
Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev (2009) 1.28
Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Ann Neurol (1987) 1.26
Hepatitis E in new zealand. J Gastroenterol Hepatol (2007) 1.23
Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant (2010) 1.23
Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol (2012) 1.23
Autochthonous hepatitis E in southwest England. J Viral Hepat (2007) 1.20
Hepatitis E virus in Scottish blood donors. Vox Sang (2013) 1.17
Neuralgic amyotrophy and hepatitis E virus infection. Neurology (2014) 1.15
Hepatitis E virus infections in blood donors, France. Emerg Infect Dis (2014) 1.15
No artifact, hepatitis E is emerging. Hepatology (2015) 1.14
Guillain-Barré syndrome following hepatitis E. World J Gastroenterol (2009) 1.10
Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol (2000) 1.09
Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang (2011) 1.09
Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology (2003) 1.07
Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis (2012) 1.07
Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg (2008) 1.06
Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol Neurosurg Psychiatry (2009) 1.06
Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol (2004) 1.01
Acute hepatitis E infection acquired in California. Clin Infect Dis (2000) 1.01
The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect (2010) 1.01
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol (2009) 1.01
Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis (2011) 0.99
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Emerg Infect Dis (2015) 0.98
Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr (2006) 0.97
The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis (2010) 0.97
Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry (2003) 0.95
Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang (2010) 0.94
Radiculoneuropathy associated with acute hepatitis E. Dig Liver Dis (2013) 0.92
Seizure associated with acute hepatitis E. Neurology (2001) 0.92
Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med (2011) 0.92
Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis (2013) 0.92
Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci (2010) 0.91
Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS (2005) 0.90
Association between hepatitis E and neurological disorders: two case studies and literature review. J Clin Virol (2014) 0.89
Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation (2012) 0.89
Guillain-Barré syndrome associated with acute hepatitis E infection. J Clin Neurosci (2012) 0.87
Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol (2011) 0.87
First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection. Infection (2011) 0.85
Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003-2005. Emerg Infect Dis (2014) 0.85
Guillain-Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection (2013) 0.85
Hepatitis E--an unexpected problem at home. Scand J Gastroenterol (2012) 0.85
[Neuralgic amyotrophy as a manifestation of hepatitis E infection]. Rev Neurol (Paris) (2012) 0.85
Hepatitis E with Gullain-Barré syndrome: still a rare association. J Neurovirol (2013) 0.84
Hepatitis E infection with Bell's palsy. J Assoc Physicians India (2006) 0.84
Hepatitis E virus and implications for blood supply safety, Australia. Emerg Infect Dis (2014) 0.83
Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion (2015) 0.82
Hepatitis E virus-induced severe myositis. J Hepatol (2012) 0.82
Acute hepatitis E complicated by Guillain-Barre syndrome in Portugal, December 2012--a case report. Euro Surveill (2013) 0.82
Severe bilateral amyotrophic neuralgia associated with major dysphagia secondary to acute hepatitis E. F1000Res (2013) 0.81
Hepatitis E-associated Parsonage-Turner syndrome, France. Clin Res Hepatol Gastroenterol (2013) 0.81
Neuralgic amyotrophy complicating acute hepatitis E infection: a rare association. BMJ Case Rep (2015) 0.81
[Shoulder pain in a 30-year-old man]. Rev Med Interne (2011) 0.80
Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound. J Neurol Sci (2015) 0.80
Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol (2010) 0.80
[Neuralgic amyotrophy associated to hepatitis E virus infection]. Med Clin (Barc) (2015) 0.80
Hepatitis E and neuralgic amyotrophy: Five cases and review of literature. J Clin Virol (2015) 0.78
[Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient]. Rev Med Interne (2013) 0.78
Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman. Emerg Infect Dis (2014) 0.78
Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria. PLoS One (2015) 0.78
Hepatitis E-associated encephalopathy in a renal transplant recipient. BMJ Case Rep (2014) 0.77
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig Dis Sci (2013) 0.77
Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger? BMJ Case Rep (2012) 0.77
Reply to Wang et al. J Infect Dis (2017) 0.75